BOSTON, May 21, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including...
Mike Grey will join a panel to discuss the future of venture capital in life sciences investing at a special event hosted by the San Diego Venture Group on September 27 in San Diego, CA.
News | 09. 20. 2012
Mike Grey will join a panel to discuss the future of venture capital in life sciences investing at a special event hosted by the San Diego Venture Group on September 27 in San Diego, CA.
